Ayala Pharmaceuticals Inc (ADXS)

[longx]

hopefully this company will come up with a new drug in 2018 that will make people free from Cancer

Wish you guys lots of luck. But I'm seeing 2018 is going to be as bad as 2017 for Advaxis investors as they're running out of cash and new offerings will further dilute the stock; and even there have been a bunch of news release/announcement in the last two years, but there are still some uncertainty on when ADXS-NEO phase-1 clinical trial will start.

Remember the name "David J. Mauro"? he was the Chief Medical Officer (CMO) as Advaxis and also the lead of MINE program (in collaboration with MSK). MINE was announced in October 2015, but 6 months later the CMO left Advaxis to join Checkmate Pharmaceutical in April 2016. Also, keep in mind that the deal between Advaxis and SGI-DNA was announced one month earlier (in March 2016). If MINE was such that good and promising technology, I don't think the CMO would leave Advaxis to join a much smaller (and still in private) pharma company with only 1 drug still in phase-1. Without the CMO, there wasn't much progress in MINE developement, and this could be the reason ADXS-NEO clinical trial delayed until 2018 and until today Advaxis still hasn't been able to find the replacement for the CMO position.

MINE announcement:
https://ir.advaxis.com/press-releases/detail/1186/advaxis-launches-minetm-collaboration

News relase on the deal with SGI-DNA:
https://ir.advaxis.com/press-releases/detail/1206/advaxis-truly-personalized-cancer-immunotherapy-moves

David J. Mauro's LinkedIn page:
https://www.linkedin.com/in/david-mauro-55917a12/